143 related articles for article (PubMed ID: 1972588)
1. [Biochemical aspects of schizophrenia].
Sano A; Kakimoto Y
Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1380-7. PubMed ID: 1972588
[No Abstract] [Full Text] [Related]
2. Biochemical aspects of schizophrenia.
Lewis ME
Essays Neurochem Neuropharmacol; 1980; 4():1-67. PubMed ID: 6104597
[No Abstract] [Full Text] [Related]
3. Schizophrenia.
Bladessarini RJ
N Engl J Med; 1977 Nov; 297(18):988-95. PubMed ID: 20577
[No Abstract] [Full Text] [Related]
4. Integrating the neurobiology of schizophrenia. Preface.
Abi-Dargham A; Guillin O
Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
[No Abstract] [Full Text] [Related]
5. [Biological research on schizophrenia. Dopamine activity of the brain in relation to the "amphetamine model"].
Fog R; Munkvad I; Randrup A
Ugeskr Laeger; 1976 Aug; 138(34):2039-41. PubMed ID: 823674
[No Abstract] [Full Text] [Related]
6. [A biochemical theory of schizophrenia].
Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME
Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120
[TBL] [Abstract][Full Text] [Related]
7. Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain.
Seeman P; Ko F; Jack E; Greenstein R; Dean B
Synapse; 2007 May; 61(5):303-9. PubMed ID: 17318883
[TBL] [Abstract][Full Text] [Related]
8. [Possibilities in the treatment of schizophrenia based on biochemical findings].
Nagashi M
Seishin Shinkeigaku Zasshi; 1985; 87(7):435-43. PubMed ID: 2867568
[No Abstract] [Full Text] [Related]
9. The significance of some biochemical abnormalities in schizophrenia.
Rodnight R
Acta Neurol (Napoli); 1975; 30(1):85-101. PubMed ID: 1063539
[No Abstract] [Full Text] [Related]
10. Schizophrenia: a neurotransmitter imbalance syndrome?
Carlsson A
Yakubutsu Seishin Kodo; 1990 Mar; 10(1):35-42. PubMed ID: 1977245
[No Abstract] [Full Text] [Related]
11. Schizophrenia.
Morrison PD; Murray RM
Curr Biol; 2005 Dec; 15(24):R980-4. PubMed ID: 16360673
[No Abstract] [Full Text] [Related]
12. Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.
Guillin O; Demily C; Thibaut F
Int Rev Neurobiol; 2007; 78():377-95. PubMed ID: 17349867
[TBL] [Abstract][Full Text] [Related]
13. Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin.
Kumamoto N; Matsuzaki S; Inoue K; Hattori T; Shimizu S; Hashimoto R; Yamatodani A; Katayama T; Tohyama M
Biochem Biophys Res Commun; 2006 Jun; 345(2):904-9. PubMed ID: 16701550
[TBL] [Abstract][Full Text] [Related]
14. Schizophrenia: diverse approaches to a complex disease.
Sawa A; Snyder SH
Science; 2002 Apr; 296(5568):692-5. PubMed ID: 11976442
[TBL] [Abstract][Full Text] [Related]
15. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia.
Kety SS
Semin Psychiatry; 1972 Aug; 4(3):233-8. PubMed ID: 4155537
[No Abstract] [Full Text] [Related]
16. [Physiopathology of schizophrenia. Some biologic aspects].
Tissot R
Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(1):29-40. PubMed ID: 6148787
[No Abstract] [Full Text] [Related]
17. Biochemistry and the schizophrenia. Old concepts and new hypothesis.
Berger PA
J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786
[TBL] [Abstract][Full Text] [Related]
18. [Biological psychiatry. 1) The dopamine-acetylcholine equilibrium model].
Adèr JP
TVZ; 1988 Jan; 42(1):13-6. PubMed ID: 2895504
[No Abstract] [Full Text] [Related]
19. Towards a muscarinic hypothesis of schizophrenia.
Raedler TJ; Bymaster FP; Tandon R; Copolov D; Dean B
Mol Psychiatry; 2007 Mar; 12(3):232-46. PubMed ID: 17146471
[TBL] [Abstract][Full Text] [Related]
20. Platelet enzyme abnormalities in neuropsychiatric disease.
Farmer PM
Ann Clin Lab Sci; 1980; 10(4):263-8. PubMed ID: 6108742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
